Question 1

Not yet. Suffolk and North East Essex NHS Integrated Care Board does have a weight management policy however this is currently under review. We plan on publishing this policy once it is finalised and therefore are withholding it under Section 22(1)(a) of the Freedom of Information Act.

We are unable to provide an exact date for it’s publication at this time but it will be published on our website once it is ready.

Question 2

a) IMD
1 2147
2 2571
3 3558
4 2581
5 1833

b) Ethnicity

Unknown 1319
Asian or Asian British 410
Black or Black British 429
Mixed 163
Other Ethnic Groups 150
Unknown/anything else 458
White 11165

c) Age

Unknown 1319
0-14 10
15-29 484
30-44 1873
45-59 3520
60-74 4569
75-89 2220
90+ 99

d) Sex

Unknown 1319
Female 7339
Male 5436

Question 3

We have enabled access to Mounjaro® in primary care settings via our community outreach service, which is part of the Weight Management and Complex Obesity Service (WMCOS).

We are planning to have community outreach clinics, known as neighbourhood accelerator access hubs, but the locations are yet to be determined. These will most likely be in support of IMD1 and IMD2 areas of deprivation as a priority. The locations will be decided by our population health management data and targeted where it is most needed.

We are working with Health Innovation East who will be evaluating the WMCOS Single Point of Access (SPoA)

Question 4

SNEE ICB was allocated a national funding variation for 25/26 for the Tirzepatide® Funding Variation’s for NICE TA 1026. We have commissioned ESNEFT through our Weight Management and Complex Obesity Service (WMCOS) to deliver a community outreach service. The funding variation has been ring fenced for access to Tirzepatide.

We have awarded as part of a contract variation with our main acute provider £2.7m for 25/26 for all services across our specialised weight management and complex obesity services, which will include an element of Tirzepatide funding. 

WMCOS is an integrated pathway which includes a full assessment of each patient’s needs and access within WMCOS - where eligible - to specialist dietary advice, obesity management medications and bariatric surgery.

We have plans to as part of our Neighbourhood accelerator access hubs to support patients of lower complexity but high need in these community outreach clinics where overtime we intend to develop services that embedding a whole-household approach to weight management within SNEE's Community Hubs, this will mean that we will engage with the Neighbourhood Health services and support to provide a holistic approach to families and their obesity needs. This is currently in the planning stages and will be developed over a 3-5 year period.